When women become pregnant, they routinely undergo several tests to screen for conditions and complications. Blood tests determine blood type and Rh factor, urine tests pinpoint kidney infections, gestational diabetes and pregnancy-induced high blood pressure, cervical tests check for STDs, cervical cancer, and Group B streptococcus infection, "triple-marker" (aka "triple screen") blood tests screen for genetic abnormalities, and ultrasound identifies the position of the baby, its gender and possible abnormalities and structural defects.
However, one important battery of tests which is not commonly administered to pregnant women is called the TORCH panel, or TORCH test. These blood tests measure the presence of antibodies and their level of concentration in the blood.
The TORCH test measures the levels of a mother's/infant's antibodies against five groups of chronic infections: toxoplasmosis, rubella, CMV, and other infections. The CMV titers test can also be administered separately from the TORCH panel to determine if a patient has already been exposed to the CMV virus and has antibodies present in their blood.
Unfortunately, given the perceived rarity of congenital CMV cases, some medical professionals do not recommend either CMV or TORCH panel testing. Some believe that routine testing of pregnant women would cause a complexity of issues to arise for both patient and physician, as well as insurance companies who generally foot the bill for such tests.
If you are currently pregnant or planning a future pregnancy, ask your physician about getting tested for CMV and tell them what you've learned about CMV and its effects on pregnancy. Knowing your immunity status is key to peace of mind, and will also help you to take appropriate preventative steps during your pregnancy.
www.stopcmv.com is Section 508 compliant (1194.22).